The Lapis ESG Global Medical Device 25 Dividend Yield Index is composed of 25 worldwide best-known and leading companies included in one of the leading ESG equity indices. All companies in our equally weighted equity index have a market capitalization greater than USD 5 billion and 80 % of them have paid uninterrupted and continuously increasing dividends over the last 5 years. Hence, a maximum of 20 % of the companies included in our unique equity index do not apply a strict dividend payment policy and have paid their regular dividends for less than 5 years. Our rule-based criteria for selecting the most promising companies are applied during the quarterly rebalancing process (end of January, April, July, and October).

This Lapis equity index is suitable for investors who are seeking a reliable income stream from companies operating in the global medical devices industry. The production of medical devices is very complex, which is why there are only a few companies that have successfully established themselves in this specialized and high-margin market. It is to be expected that the industry will continue to show high sales and profit growth rates in the future due to the increasing ageing of society and the simultaneous high willingness to pay for medical devices and health care.